BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14328737)

  • 1. COMMUNICATION OF BODY COMPLAINTS AND PARANOID SYMPTOM CHANGE UNDER CONDITIONS OF PHENOTHIAZINE TREATMENT.
    FREEDMAN N; ENGELHARDT D; MANN D; MARGOLIS R; LONDON S
    J Pers Soc Psychol; 1965 Apr; 1():310-8. PubMed ID: 14328737
    [No Abstract]   [Full Text] [Related]  

  • 2. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.
    ENGELHARDT DM; FREEDMAN N; ROSEN B; MANN D; MARGOLIS R
    Arch Gen Psychiatry; 1964 Aug; 11():162-9. PubMed ID: 14237612
    [No Abstract]   [Full Text] [Related]  

  • 3. FACTORS INFLUENCING THE CLINICAL RESPONSES OF SCHIZOPHRENIC PATIENTS TO PHENOTHIAZINE DRUGS AND TO PLACEBO.
    KLERMAN GL; DAVIDSON EM; KAYCE MM
    Psychiatr Res Rep Am Psychiatr Assoc; 1964 Dec; 19():97-115. PubMed ID: 14232660
    [No Abstract]   [Full Text] [Related]  

  • 4. CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.
    GOLDBERG SC; KLERMAN GL; COLE JO
    Br J Psychiatry; 1965 Feb; 111():120-33. PubMed ID: 14270524
    [No Abstract]   [Full Text] [Related]  

  • 5. SENSORY CHANGES WITH PHENOTHIAZINE MEDICATION IN SCHIZOPHRENIC PATIENTS.
    LLOYD DN; NEWBROUGH JR
    J Nerv Ment Dis; 1964 Aug; 139():169-75. PubMed ID: 14208256
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECTS OF PHENOTHIAZINE ON DISORDERED THOUGHT IN SCHIZOPHRENIA.
    CHAPMAN LJ; KNOWLES RR
    J Consult Psychol; 1964 Apr; 28():165-9. PubMed ID: 14142951
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECTS OF ACETOPHENAZINE DIMALEATE ON PARANOID SYMPTOMATOLOGY IN FEMALE GERIATRIC PATIENTS: DOUBLE-BLIND STUDY.
    SHEPPARD C; BHATTACHARYYA A; DIGIACOMO M; MERLIS S
    J Am Geriatr Soc; 1964 Sep; 12():884-8. PubMed ID: 14212064
    [No Abstract]   [Full Text] [Related]  

  • 8. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. II. DURATION OF TREATMENT EXPOSURE.
    ENGELHARDT DM; ROSEN B; FREEDMAN N; MANN D; MARGOLIS R
    JAMA; 1963 Dec; 186():981-3. PubMed ID: 14066719
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECTS OF PSYCHOTROPIC DRUGS ON LONG-TERM ADJUSTMENT. A REVIEW.
    GITTELMAN RK; KLEIN DF; POLLACK M
    Psychopharmacologia; 1964 Apr; 5():317-38. PubMed ID: 14151546
    [No Abstract]   [Full Text] [Related]  

  • 10. On the modification of paranoid symptomatology.
    Freedman N; Cutler R; Engelhardt DM; Margolis R
    J Nerv Ment Dis; 1967 Jan; 144(1):29-36. PubMed ID: 5337100
    [No Abstract]   [Full Text] [Related]  

  • 11. PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION.
    GANTZ RS; BIRKETT DP
    Arch Gen Psychiatry; 1965 Jun; 12():586-8. PubMed ID: 14286887
    [No Abstract]   [Full Text] [Related]  

  • 12. On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines.
    Freedman N; Cutler R; Engelhardt DM; Margolis R
    J Nerv Ment Dis; 1970 Jan; 150(1):68-76. PubMed ID: 4906641
    [No Abstract]   [Full Text] [Related]  

  • 13. LONG TERM DRUG-INDUCED SYMPTOM MODIFICATION IN SCHIZOPHRENIC OUTPATIENTS.
    ENGELHARDT DM; FREEDMAN N; HANKOFF LD; MANN D; MARGOLIS R
    J Nerv Ment Dis; 1963 Sep; 137():231-41. PubMed ID: 14051937
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative comparison of clinical effectiveness of chlorpromazine and promazine.
    GILMORE TH; SHATIN L
    J Ment Sci; 1959 Apr; 105(439):508-10. PubMed ID: 13665315
    [No Abstract]   [Full Text] [Related]  

  • 15. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
    BISHOP MP; GALLANT DM
    Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled comparative investigation of the effects of promazine, chlorpromazine, and a placebo in chronic psychosis.
    FLEMING BG; SPENCER AM; WHITELAW EM
    J Ment Sci; 1959 Apr; 105(439):349-58. PubMed ID: 13665296
    [No Abstract]   [Full Text] [Related]  

  • 18. The hospitalization proneness scale as a predictor of response to phenothiazine treatment. II. Delay of psychiatric hospitalization.
    Rosen B; Engelhart DM; Freedman N; Margolis R; Klein DF
    J Nerv Ment Dis; 1971 Jun; 152(6):405-11. PubMed ID: 4935067
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician bias and the double-blind.
    Engelhardt DM; Margolis RA; Rudorfer L; Paley HM
    Arch Gen Psychiatry; 1969 Mar; 20(3):315-20. PubMed ID: 4884940
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INFLUENCE OF PREVIOUS HOSPITALIZATION ON THE CLINICAL COURSE OF PSYCHOPHARMACOLOGICALLY TREATED SCHIZOPHRENIC OUTPATIENTS.
    ENGELHARDT D; FREEDMAN N; MANN D
    Compr Psychiatry; 1963 Oct; 4():337-42. PubMed ID: 14055432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.